case_images: PMC10950357_01
case_images: Biomicroscopic view of a mass measuring 7 x 10 mm, with telangiectasias and preserved eyelashes.
case_images: cro-2024-0017-0001-537860_F01.jpg
case_images: PMC10950357_01_cro-2024-0017-0001-537860_F01.jpg
case_images: F1
case_images: The mass is red in color, covered with telangiectasias, with preserved eyelashes at the tumor site (Fig. 1).
case_images: Pathohistological finding of the eyelid tumor: material sheathed with partially ulcerated epidermis, made of trabecularly arranged, polymorphic, polygonal cells with clear cytoplasm. Tumor was well divided from the surrounding tissue, with pathologic mitosis and mitotic active tumor cells and without necrosis. The upper part is x40 and the lower is x200 magnification.
case_images: cro-2024-0017-0001-537860_F02.jpg
case_images: PMC10950357_01_cro-2024-0017-0001-537860_F02.jpg
case_images: F2
case_images: The tumor does not reach the edges of the skin sample in the examined histological sections (Fig. 2).
case_images: Abdominal CT shows a confirmed, expansive mass at the lower pole of the right kidney.
case_images: cro-2024-0017-0001-537860_F03.jpg
case_images: PMC10950357_01_cro-2024-0017-0001-537860_F03.jpg
case_images: F3
case_images: There were no enlarged lymph nodes, ascites, and metastases (Fig. 3).
case_images: Pathohistological findings were showing a kidney, measuring 13 x 5 x 6 cm, with well-bordered tumor in its lower pole, gray colored, with 6 cm in diameter, that macroscopically did not penetrate the capsule and with up to 20% of necroses. The upper part of the picture shows x40 magnification, and the lower part shows magnification of x100.
case_images: cro-2024-0017-0001-537860_F04.jpg
case_images: PMC10950357_01_cro-2024-0017-0001-537860_F04.jpg
case_images: F4
case_images: The pathohistological findings showed a kidney with dimensions of 13 x 5 x 6 cm, with a well-limited tumor with a diameter of 6 cm in the lower pole, gray in color, which macroscopically does not penetrate the capsule and with up to 20% necrosis (Fig. 4).
case_images: There are no signs of local tumor recurrence or new metastases at the eye, as seen at 6 months after tumor excision.
case_images: cro-2024-0017-0001-537860_F05.jpg
case_images: PMC10950357_01_cro-2024-0017-0001-537860_F05.jpg
case_images: F5
case_images: There are no signs of local tumor recurrence or new metastases in the eye or anywhere else in the body (Fig. 5).